SRZN

Surrozen, Inc.

11.18 USD
+1.49 (+15.38%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Surrozen, Inc. stock is up 8.65% since 30 days ago. The next earnings date is Aug 7, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 3 June’s closed higher than May.

About Surrozen, Inc.

Surrozen, Inc. discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. It is developing tissue-specific antibodies with application across various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system.